Testing for COVID-19 is now faster and easier than ever before with the announcement from Franklin Lakes-based BD (Becton, Dickinson and Co.), which on Aug. 25 said it was granted an Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA) for its Veritor At-Home COVID-19 Test.
This first at-home COVID-19 rapid antigen test uses computer vision technology in a smartphone to interpret and provide a digital display of testing results. It does not require a prescription, a laboratory or a long wait for results.
The test will initially be made available to businesses, schools and governments looking to provide a self-testing option for employees or students.
Dave Hickey, president of life sciences for BD, recently spoke with NJBIZ Editor Jeff Kanige about the innovative product. “The rise in COVID-19 cases from the delta variant has increased the demand for at-home testing, and the BD Veritor At-Home COVID-19 Test is an easy-to-use test with definitive digital results that is ideal for use in the home,” said Hickey of the EUA approval.
With a simple nasal swab and an easy-to-use mobile app from Scanwell Health, results are available in as little as 15 minutes.
The app is available on iOS and Android and provides step-by-step instructions. The mobile device’s camera is used to capture, analyze and interpret the results, which eliminates the human subjectivity of a visually read test. The BD Veritor At-Home COVID-19 Test is designed to be easily performed at home by people 14 years of age or older, using the app to provide clear digital results in 15 minutes.
The test can also be used for children as young as 2 years old with samples collected by an adult. The simple and straightforward testing experience includes a pain-free nasal swab, video instructions that guide users through each step and built-in timers so users can self-test with confidence.